scholarly journals AB0541 LUPUS MANIFESTATIONS IN A PATIENT WITH SPONDYLOARTHRITIS TREATED WITH TUMOUR NECROSIS FACTOR-ALPHA ANTAGONIST: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) OR DRUG-INDUCED LUPUS ERYTHEMATOSUS (DILE)?

2019 ◽  
Author(s):  
Mariam Hamid Mustapha ◽  
Syang Pyng Gan ◽  
Hazlyna Baharuddin ◽  
Norliza Zainudin ◽  
Shereen Suyin Ch’ng
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Tumour Necrosis ◽  
Tumour Necrosis Factor Alpha ◽  
Systemic Lupus ◽  
Drug Induced ◽  
Necrosis Factor Alpha ◽  
Factor Alpha ◽  
Alpha Antagonist ◽  
Necrosis Factor

scholarly journals Increased Frequency of the Uncommon Allele of a Tumour Necrosis Factor Alpha Gene Polymorphism in Rheumatoid Arthritis and Systemic Lupus Erythematosus

1994 ◽  
Vol 12 (2) ◽  
pp. 127-133 ◽  
Author(s):  
Victor A. Danis ◽  
Michelle Millington ◽  
Valentine Hyland ◽  
Ron Lawford ◽  
Qirong Huang ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Tumour Necrosis Factor ◽  
Lupus Erythematosus ◽  
Tumour Necrosis ◽  
Tumour Necrosis Factor Alpha ◽  
Systemic Lupus ◽  
Necrosis Factor Alpha ◽  
Factor Alpha ◽  
Necrosis Factor

The frequency of the uncommon allele (TNF2) of a polymorphism in the promoter region of the tumour necrosis factor alpha (TN Fα) gene in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) was found to be 3 times that of the normal anglo-saxon population. In SLE patients, this allele was strongly associated with HLA-DR3 expression and was also more frequent in patients who did not have malar rash. Functional studies of normal monocyte cytokine production in vitro showed that this genotype was associated with increased IL-1α protein production but there were no differences in the production of TNFα protein.

Sign in / Sign up

Export Citation Format

Share Document